Concepedia

Frank C. Albers

FC

39

Publications

3.9K

Citations

28

H-Index

1957

Active since

Affiliations

Research Triangle Park Foundation(Current)

GlaxoSmithKline (United States)

GlaxoSmithKline (United Kingdom)

Capital Allergy and Respiratory Disease Center

University of Ferrara

Frank C. Albers is an author at Research Triangle Park Foundation specializing in medicine, asthma, and allergy.

ORCID

Top concepts

Publications per year

1957–2025

39

Publications

39

Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial

Geoffrey Chupp, Eric Bradford, Frank C. Albers et al. · The Lancet Respiratory Medicine · 2017 · 571 citations

, , +10

Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease

Ian Pavord, Pascal Chanez, Gerard J. Criner et al. · New England Journal of Medicine · 2017 · 563 citations · Full text

Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma

Sumita Khatri, Wendy C. Moore, Peter G. Gibson et al. · Journal of Allergy and Clinical Immunology · 2018 · 289 citations · Full text

The frequency of asthma exacerbations and healthcare utilization in patients with asthma from the UK and USA

Robert Suruki, Jonas Daugherty, Nada Boudiaf et al. · BMC Pulmonary Medicine · 2017 · 274 citations · Full text

Acute and chronic systemic corticosteroid–related complications in patients with severe asthma

Patrick Lefèbvre, Mei Sheng Duh, Marie‐Hélène Lafeuille et al. · Journal of Allergy and Clinical Immunology · 2015 · 209 citations

, , +5

Rows per page

1–5 of 39